This inventor holds 2 USPTO granted patents and 5 published patent applications, plus 1 CIPO patent and 4 EPO patents. Top assignee: Nipd Genetics Public Company Ltd. Active years: 2024-2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2024-2025
Title: Charalambos Loizides: Innovator in Tumor Biomarker Assessment
Introduction
Charalambos Loizides is a notable inventor based in Nicosia, Cyprus. He has made significant contributions to the field of genetic analysis, particularly in the assessment of tumor biomarkers and genetic conditions. With two patents to his name, his work is paving the way for advancements in medical diagnostics.
Latest Patents
Loizides' latest patents include innovative methods for the assessment of tumor biomarkers and genetic conditions. The first patent, titled "Target-enriched multiplexed parallel analysis for assessment of tumor biomarkers," provides methods that utilize Target Capture Sequences (TACS) to enrich target sequences of interest. This method allows for massive parallel sequencing and statistical analysis of enriched populations, enabling the detection of tumor biomarkers from DNA samples, such as tissue biopsies or plasma samples. The invention is aimed at improving diagnosis, screening, therapy selection, and treatment monitoring. The second patent, "Target-enriched multiplexed parallel analysis for assessment of risk for genetic conditions," focuses on prenatal testing. It employs similar methods to determine the fetal risk of inheriting genetic conditions by assessing carrier status of inheritable genetic abnormalities.
Career Highlights
Charalambos Loizides is currently associated with Nipd Genetics Public Company Ltd., where he continues to innovate in the field of genetic testing. His work is instrumental in developing methods that enhance the accuracy and efficiency of genetic assessments.
Collaborations
Loizides collaborates with esteemed colleagues, including George Koumbaris and Marios Ioannides, to further advance research and development in genetic diagnostics.
Conclusion
Charalambos Loizides is a prominent figure in the field of genetic analysis, with his patents contributing significantly to the assessment of tumor biomarkers and genetic conditions. His work exemplifies the impact of innovation in improving medical diagnostics and patient care.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile